Cidara Therapeutics (CDTX)
(Delayed Data from NSDQ)
$13.00 USD
+0.71 (5.78%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $12.89 -0.11 (-0.85%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -1.40 |
EPS Last Quarter | -0.04 |
Last EPS Surprise | NA |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -13.00 |
Next Year | 12.60 |
EPS (TTM) | -0.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 14.50M | 3.30M | 27.91M | 107.17M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 14.50M | 3.30M | 27.91M | 107.17M |
Low Estimate | 14.50M | 3.30M | 27.91M | 107.17M |
Year ago Sales | 25.99M | 7.61M | 63.90M | 27.91M |
Year over Year Growth Est. | -44.21% | -56.64% | -56.33% | 283.98% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.40 | -4.00 | -13.00 | 12.60 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.07 | -0.20 | -0.65 | 0.63 |
High Estimate | -1.40 | -4.00 | -13.00 | 12.60 |
Low Estimate | -1.40 | -4.00 | -13.00 | 12.60 |
Year ago EPS | 0.03 | -0.14 | -0.26 | -13.00 |
Year over Year Growth Est. | -4,766.67% | -2,757.14% | -4,900.00% | 196.92% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.40 | -4.00 | -13.00 | 12.60 |
7 Days Ago | -1.40 | -4.00 | -13.00 | 12.60 |
30 Days Ago | -1.40 | -4.00 | -13.00 | 12.60 |
60 Days Ago | -1.40 | -4.00 | -13.00 | 12.60 |
90 Days Ago | -1.40 | -4.00 | -13.00 | 12.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.40 | -4.00 | -13.00 | 12.60 |
Zacks Consensus Estimate | -1.40 | -4.00 | -13.00 | 12.60 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.04 | -0.09 | -0.14 | 0.03 | NA |
Estimate | NA | -0.14 | -0.08 | 0.06 | NA |
Difference | NA | 0.05 | -0.06 | -0.03 | -0.01 |
Surprise | NA | 35.71% | -75.00% | -50.00% | -29.76% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more